ESAT-6 (EsxA) and TB10.4 (EsxH) based vaccines for pre- and post-exposure tuberculosis vaccination.
about
The Zebrafish Breathes New Life into the Study of TuberculosisTuberculosis vaccines and prevention of infectionRecent advances in the development of vaccines for tuberculosisTB vaccines; promoting rapid and durable protection in the lungTesting the H56 Vaccine Delivered in 4 Different Adjuvants as a BCG-Booster in a Non-Human Primate Model of TuberculosisTargeting dendritic cells to accelerate T-cell activation overcomes a bottleneck in tuberculosis vaccine efficacyNovel vaccination strategies against tuberculosis.Protein energy malnutrition during vaccination has limited influence on vaccine efficacy but abolishes immunity if administered during Mycobacterium tuberculosis infectionFrom mouse to man: safety, immunogenicity and efficacy of a candidate leishmaniasis vaccine LEISH-F3+GLA-SE.Comparative Genomics and Proteomic Analysis of Four Non-tuberculous Mycobacterium Species and Mycobacterium tuberculosis Complex: Occurrence of Shared Immunogenic ProteinsDifferent human vaccine adjuvants promote distinct antigen-independent immunological signatures tailored to different pathogensNew Genome-Wide Algorithm Identifies Novel In-Vivo Expressed Mycobacterium Tuberculosis Antigens Inducing Human T-Cell Responses with Classical and Unconventional Cytokine Profiles.Introducing the ESAT-6 free IGRA, a companion diagnostic for TB vaccines based on ESAT-6.Mycobacterium tuberculosis virulence: insights and impact on vaccine development.Global Efforts in the Development of Vaccines for Tuberculosis: Requirements for Improved Vaccines Against Mycobacterium tuberculosis.Antigen Availability Shapes T Cell Differentiation and Function during Tuberculosis."The Impact of Mycobacterium tuberculosis Immune Evasion on Protective Immunity: Implications for TB Vaccine Design" - Meeting report.Heterologous boosting with recombinant VSV-846 in BCG-primed mice confers improved protection against Mycobacterium infection.Reprogramming the T Cell Response to Tuberculosis.Designing and Construction of a DNA Vaccine Encoding Tb10.4 Gene of Mycobacterium tuberculosisMycobacterium tuberculosis components expressed during chronic infection of the lung contribute to long-term control of pulmonary tuberculosis in mice.Multi-stage subunit vaccines against Mycobacterium tuberculosis: an alternative to the BCG vaccine or a BCG-prime boost?A phase I, open-label trial on the safety and immunogenicity of the adjuvanted tuberculosis subunit vaccine H1/IC31® in people living in a TB-endemic area.High Antigen Dose Is Detrimental to Post-Exposure Vaccine Protection against Tuberculosis.T Cells Primed by Live Mycobacteria Versus a Tuberculosis Subunit Vaccine Exhibit Distinct Functional Properties.Identification of Mycobacterial Ribosomal Proteins as Targets for CD4 T Cells That Enhance Protective Immunity in Tuberculosis
P2860
Q26744620-FB04D13C-8FFA-4180-B18E-4B2594A1D683Q26782022-971ACC51-4A59-4BC9-A2E7-1B35DC9B1A45Q26796440-ABCA24CD-064A-4826-9564-4A0718D131EAQ27007497-340822ED-CF7E-46F0-B433-90882FABC0F1Q27327288-E8F6D4C8-EAD8-4E57-BE24-8AD150F6F2CFQ28354371-9297CF2E-878A-4796-805B-91CAEDB80546Q30363188-D348CA25-4084-4F08-883A-AB406B07B57AQ35439452-1B68C535-DA36-445F-A845-529DDFDE5664Q35809113-38AD79F3-F1DC-4F3A-AFD2-0E38478C7011Q36067221-3F5D9D2E-B554-4680-BCB2-72897D1B48BBQ36500269-2A81B4F2-021A-49EE-A4EB-00BD31BFE664Q37445202-46BBFFF0-D129-4A31-A1E5-BBCCC270D449Q37741088-94D2AE89-6B99-4531-BD5A-F643B7D6DBF4Q38539493-ABB7164E-32DB-4F5F-AFC2-83D8A290BA13Q38907507-C54C8C41-346A-47EC-B9F9-82F9B9C3701FQ40171033-E431C6BC-D836-440E-9E16-0A527CF45F23Q40213126-F06B0448-7C69-4B83-9B94-2CDED1AACA0BQ40411515-5F52F061-EC39-4605-8A78-75E1A5039EF7Q40829662-1E8711A1-9B83-46F7-9944-F2EBCF345C2EQ41868696-C15505F9-FEC4-41FA-9947-7006E9BD8BF9Q47159990-D311D97F-A4D6-413B-AEAD-F7B91D059FE5Q47834561-27C9DDFA-29BB-4144-9661-278484849320Q48268531-4FC2505D-C275-4242-98E6-4163878DEDF1Q49310880-49CE54D0-A8E4-44E5-BA8B-E2A533E312EEQ49713237-AA860F68-F3EA-4F7F-846A-90B04A0242C2Q56976379-47FC20E8-0AFD-4C25-AB8F-D43764E8AB72
P2860
ESAT-6 (EsxA) and TB10.4 (EsxH) based vaccines for pre- and post-exposure tuberculosis vaccination.
description
2013 nî lūn-bûn
@nan
2013 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2013 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2013年の論文
@ja
2013年学术文章
@wuu
2013年学术文章
@zh-cn
2013年学术文章
@zh-hans
2013年学术文章
@zh-my
2013年学术文章
@zh-sg
2013年學術文章
@yue
name
ESAT-6 (EsxA) and TB10.4 (EsxH ...... sure tuberculosis vaccination.
@ast
ESAT-6 (EsxA) and TB10.4 (EsxH ...... sure tuberculosis vaccination.
@en
type
label
ESAT-6 (EsxA) and TB10.4 (EsxH ...... sure tuberculosis vaccination.
@ast
ESAT-6 (EsxA) and TB10.4 (EsxH ...... sure tuberculosis vaccination.
@en
prefLabel
ESAT-6 (EsxA) and TB10.4 (EsxH ...... sure tuberculosis vaccination.
@ast
ESAT-6 (EsxA) and TB10.4 (EsxH ...... sure tuberculosis vaccination.
@en
P2093
P2860
P1433
P1476
ESAT-6 (EsxA) and TB10.4 (EsxH ...... sure tuberculosis vaccination.
@en
P2093
Carina Vingsbo Lundberg
Claus Aagaard
Else Marie Agger
Gary K Schoolnik
Gregory Dolganov
Jes Dietrich
Joseph P Cassidy
Truc Hoang
P2860
P304
P356
10.1371/JOURNAL.PONE.0080579
P407
P577
2013-12-12T00:00:00Z